Experts Meeting on Cancer Medicine, Radiology & Treatment June 29-30, 2020 Athens, Greece

Barbara DeVivo has spent her entire career in marketing management serving various executive global roles from market analysis and research, business development product management and professional relations. Ms. DeVivo has also amassed a strong proficiency in all facets of marketing management, sharing both academic and professional experiences. Currently, Ms. DeVivo is a PhD student at the State University of New York at Albany- Rockefeller College of Public Affairs and Policy whose research is centered on Organizational Behavior Management in Healthcare.

Organizational Behavior Management in Healthcare

Dr. El Hadji Seydou Mbaye was born in 1978 in Kaolack a region of Senegal. During 2008-2013, he earned his PhD in Biology and Human Pathologies with the collaboration of the International Agency for Research on Cancer (IARC) /WHO, Lyon (France); 2006-2007 : Master of Life and Health, Specialty Biology of microorganisms, Virology in Louis Pasteur University of Strasbourg (France); 2005-2006 : Master of Life and Health, option of Immuno-physiopathology in Louis Pasteur University of Strasbourg (France); 2004-2005 : License of Biochemistry in Louis Pasteur University of Strasbourg (France); 2002-2004 : General Degree in Sciences and Technologies in University of METZ (France).

cervical cancer screening

Mike is the former Director of Consumer Affairs and Communications at The American Academy of Cannabinoid Medicine. His post grad education, however is not in cannabis or cannabinoid medicine, rather it’s focus was International Relations and Diplomacy. Robinson has an extensive history of leading a large compassion program that provided countless disadvantaged cannabis patients with various alternative protocol treatments, is a published journalist and international cannabinoid research specialist, is a former registered Civil Rights lobbyist and non attorney that represented countless disabled children pro bono nationwide for over 2 decades. He’s a past board member of Big Brothers and Sisters, the founder of multiple non profits for disabled children, and is well known for adopting a severely disabled child, Genevieve, from the compassion program he once ran.

Cancer survivor, Severe epilepsy, Chronic Lyme Disease

Claude Prigent has completed his PhD at the age of 30 years from Rennes University in France and postdoctoral studies from Imperial Cancer research Fund, Clare Hall Lab in London, UK. He is the director of research in the CNRS : National Center for Scientific Research in Freance. He has published more than 110 papers in reputed journals.

Cancer Cell Biology

Dimitrios H. Roukos, MD, PhD, is Professor of Surgery – Precision Cancer Medicine and Founding director of “Centre for Biosystems and Genome Network Medicine” in the Ioannina University, School of Medicine. Following conventional surgical oncology research, he has shifted into interpatient heterogeneity-based Personalized Cancer Medicine combining clinico-pathologic and single gene characteristics. Recently, he is exclusively focusing on intratumor multi-regional and even single-cell genetic, genomic, transcriptional and regulatory network heterogeneity-based drug resistance and relapse towards future clinical Precision Oncology. He has developed and published 3 breakthrough concepts to overcome clinical unmet needs. He has published > 240 PubMed papers, 36 on Precision Medicine and Oncology, and 80 on static and spatiotemporal genome analysis with NGS. These publications have received more than 9000 citations with h-index: 75 (Scopus). He is reviewer in many high impact journals including some with impact factor (IF) >30, evaluator in innovative research projects (EU, France, Italy, Belgium, Luxemburg, Poland), member in the editorial board of 25 international journals with IF, as well as Organizing Committee member and Invited lectures in > 130 International Conferences.

Precision Cancer Medicine,Cancer Diagnostics,Cancer Biomarkers

Jana Slobodnikova. M.D., end study on Charles University in Prague., gradued - CSc / PhD / completed at the age 38 years from Institus of Experimental Oncology Slovac Scientic Academy. Ass. Prof. in 43 years from Trnaviensis University, Prof. emeritus at age 45 years from St. Elizabeth High Scool. I have lectured at several universities - Prague, Tren?ín, Trnava and Bratislava. I am the author of teaching script, university textbooks, I lead workshops, I organize international congresses and worksops Her has published more than 90 scientific papers, from then 25 papers in renomed journals and has been serving as an 5 editorial board member of repute. Her has published 3 monography, Her founded the Section of Breast Imaging in 1996, from 1996 her is president The Section of Breast Imaging of Slovak radiologic Society and vice president The Slovak Society of Ultrasound in Medicine. Membership in organizations : ECR, EUSOBI, EFSUMB , SSUM ( Slovak Society of Ultrasound in Medicine ) and SRS ( Slovak Radiology Society).

Radiology, Diagnosis of breast cancer, Screening, Radiology in oncology, Diagnosis and treatment of complications after breast spectrum of laboratory examination methods in Oncology, Tumor markers, Immunohistochemistry, biopsy surgery, treatment and diagnosis of lymphedema

Dr Mari Aparici, MD is a Clinical Professor at Stanford University. She is a Nuclear Physician with residencies in both Europe (Barcelona) and US (Stanford), and with Molecular imaging fellowships from Stanford University. She is a physician-scientist in the development of Molecular Imaging. She has more than 20 years of clinical and research experience in the field, more than 10 years of a leadership position as Chief Nuclear Medicine at the San Francisco VAMC as part of her prior appointment as a UCSF faculty member, and now as Head of the Theranostics and Nuclear Therapies program at Stanford University. She has published more than 100 papers in reputed journals, has been serving as an editorial board member of reputed journals, has been PI of NIH and non-NIH grants and serves as a member of several to committees at her University and several Societies.

Clinical Focus on Radiology & Nuclear Medicine

Graduated from Toho Academy of Music in Tokyo, as a pianist and composer, invited by the Boston Symphony, she came to the USA in 1961 as one of the first Japanese women. She then received Master of Art from New York University and finished her Ph.D. credits in Philosophy in 1965. In 1967, Tatsumura then turned to an independent career and became the top International Classical and Cultural Impresario/producer. Until 1992, she produced an average of 2,000 cultural events each year, traveling to more than 140 countries. She was presented with numerous honors for her work from different countries, many for humanitarian causes. She is also well known as a philanthropist. She studied Oriental Traditional Medicine of Japan, Korea, Taiwan and China. In 2000 she received her PHD and OMD from the International Academy of Education in Tokyo. She established the Oki-Do Holistic Health Center in 1994 in NY and in 2001 the GAIA Holistic Center (501C3 nonprofit organization) at the wake of 9/11 tragedy, for body mind and spirit, aiming for the noninvasive natural healing methods based on the wisdom of the East.

She invented special holistic healing method called ONNETSU THERMOTHERAPY using Heat and 2 vibrations of Sun Far Infra-red (8-10μ) and Terahertz from deep earth planet minerals. The therapy has been widely hailed in hospitals and clinics especially in South Americas. Her invention is patent pending worldwide. “Overcoming Cancer and Other Diseases in a Holistic Way”, “Your Immune Revolution & Healing Your Healing Power”

Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynasty medical doctors. In 1980, graduated from Astrakhan State Medical University and was awarded with MD. In 1985, maintained his PhD as a PhD student of the I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology, USSR Academy of Medical Sciences, Moscow, Russia. In 2001, finished the PostDoc Research Fellowship Program and maintained his Doctor Degree at the National Institute of Immunology, Russia. From 1985 through 1987, worked at Inst of Med Enzymology, USSR Academy of Medical Sciences. From 1987 through 1989, was a senior Researcher, Koltzov Inst of Developmental Biology, USSR Academy of Sciences. From 1989 through 1995, was being a Head of the Lab of Clinical Immunology and Immunobiotechnology, Helmholtz Eye Research Inst in Moscow. From 1995 through 2004, was being a Chairman of the Dept for Clinical Immunology, Moscow Clinical Research Institute (MONIKI) and the Immunologist-in-Chief of the Moscow Regional Ministry of Health. In 1993-1996, was an Executice Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. Dr Suchkov is a Co-Supervisor over the Russian-American Agreement on scientific and clinical collab-oration in the field of ocular immunology between Russian Academy of Sciences and National Insti-tutes of Health (NIH); in 1991-1995 – a member of The Reciprocal Exchange Fellowship Program between Russian Immunological Society and British Society for Immunology. Dr Suchkov is a member of the Editorial Boards of many international journals including EPMA Jour-nal (Springer, Brussels) and “Personalized Medicine Universe” (Elsevier, Japan).

Clinical Immunology and Immunobiotechnology

Surgeon Paik was born in Iksan, Jeonbuk, Korea. He graduated from Seoul National University College of Medicine, ther after served as director of Korea Cancer Center Hospital, director of Konkuk University Medical Center, chairman of Korean Breast Cancer Society and chairman of Asia Breast Cancer Society. In 1986, he became the first surgeon to carry out breast-conserving surgery (BCS) in Korea. In 1991, he developed ‘Paik Nam-sun Stomach Cancer Surgery’ that reduces the risk of reflux oesophagitis. Such achievements earned him a spot on a list of the world’s top 100 gastric and breast cancer surgeons, unveiled by the international Biographical Center of Cambridge in the UK in 2006. He is unequivocally the No.1 breast cancer specialist in and outside Korea. 출처 : Korea IT Times(http://www.koreaittimes.com)

“The sufferings of breast cancer patients do not end after surgery. Breast cancer survivors, who had to have their breasts removed or disfigured, cannot go to public bathhouses or get divorced by their husbands. Their heartbreaking stories had prompted me to focus on breast-conserving surgery,” said breast cancer specialist Paik Nam-sun, Director of the Ewha Womans University Cancer Center for Women (hereafter EWUCCW). 출처 : Korea IT Times(http://www.koreaittimes.com)

Dr.Salah Aref is currently working as professor of Hematology in Mansoura University; Egypt. He is also working as Member in National board for promotion of Professors in Hematology. He completed his education from The Mansoura University. Dr. Salah Aref received many awards and honors: from Egyptian National Academy of Science and International Society of Laboratory Hematology. He is acting as Editorial Board Member and Peer Reviewer of many peer reviewed journals and authored many books.

Hematological Oncology,Thalassemias,Molecular Study of Hematological Disorders,Angiogenesis in Hematological Malignancies

DR Jehad Zweiri, lecturer in Cancer studies at the University of Liverpool Medical School, born and grew up in Jordan and received his Bachelor’s degree from the University of Jordan. He obtained his master degree from London School of Hygiene and Tropical Medicine/University of London, and then obtained his PhD degree in 2000 from Kings College Medical School/University of London, in the field of Immune Gene Therapy of Cancer under the supervision of Professor Farzin Farzaneh. He then started his work as Postdoctoral Associate at the department of Immunology and Medicine at the University of Liverpool in 2002. In 2010 he was appointed as a lecturer in the University of Liverpool Medical School and he is currently fellow of the British Higher Education Academy since 2012.

tumour Immunology and Cancer Vaccines

Abdalla Abotalleb is one of the most profound experts in healthcare policy and regulations in the MENA region. His expertise extends from HTA & Reimbursement policies to regulatory and supplies chain strategies in the public sector. He has been involved in the fields of health economics, outcomes research, Health policy reforming and reimbursement policies within the healthcare industry for 15 years, with experience across the pharmaceutical, biologicals and vaccines. And now works for WHO as a project manager at the health care reforming area. Abdalla Abotaleb graduated in the faculty of pharmacy then obtained a post-graduate in health economics followed by a Ph.D. in Health Economics & Policy form York University. He also has a degree in Project management professional (PMP), Pharm. D certificate and a Master of business administration (MBA).

Selecting the right patient for the right treatment with the efficient cost is the main goal for an effective health system. When Lung cancer comes at top 20 cause of death in and third rank in mortality rates among all cancer types in Egypt due to previous facts and high population for Egypt which categorized as low income country which lead to Increase economic burden on health care system and creating a need for managing and minimizing that burden plus how policy maker enhance patient’s outcomes (clinical aspect–economic aspect–quality of life aspect). The objective of this study is policy analysis for Health care policymaker in oncology for diversion of concept for reimbursement system from price into economic value and it is consequences on patient outcomes and health system resources. By analyzing Reimbursement case for Oral Vinorelbine at Non-Small-Cell Lung Cancer

Dr Sambhaji Govind Chintale is an MS Otorhinolaryngology .Associate professor @ JIIUS IIMSR Badnapur dist. Jalna Muhs Nashik University Maharashtra, India. Director cosmoent superspeciality Hospital Aurangabad Maharashtra, India .Professor is speaker @ National and International Conferences. Member of association of Otorhinolaryngologist of India. Member of Indian Medical Association, Member of American thyroid association, Indian Society of Thyroid Surgeon, member of Asia Pacific Thyroid Society. Official editor to more than 25 International and National Journals.

Otorhinolaryngology and Head and Neck Surgery

Presented papers at various International conferences including ALL INDIA INSTITUTE OF MEDICALL SCIENCES New Delhi 2009 and 2012 for their conferences on Gerontology and Geriatric Medicine and WORLD ALLERGY ORGANISATION OF US for their conferences on Allergy, Asthma and Immunology 2010 and 2012, National conferences on pulmonary diseases at Bhubaneswar and Chennai, Indo Global Health Care summit and Expo , International conference in 2014 at Hyderabad. He has been given award for Excellence in Health Care by the Organizers of the International conference. He has also presented paper at AIIMS New Delhi, for their International conference on Multidisciplinary Health Care 2014 and 2016 and many others as stated below: He has presented papers at international cancer conferences , Indo global cancer therapy conference at Hyderabad and Global cancer conference at Bengalore November 2015, International conference on Radiation Oncology and Anti-Cancer Therapy , at Dubai in the year 2016 November 21st and 22nd , In addition to the above, he has presented papers ( Video presentations ) at 25th World Congress on CANCER SCIENCE AND THERAPY and 10th World Congress on BIOMARKERS & CLINICAL RESEARCH Conference at Baltimore USA 18th – 20 October 2017, INNOVATE CANCER THERAPY conference at Brisbane , Australia , 29th 30th November, 2017 . His has been taken as an Advisory Board Member. He has demonstrated exercises on a few patients at the Institute and the patients could get relief within minutes. He has been issued a certificate to the said effect by Dr Vandana, the In charge of the Institute. He is treating patients at Mega Health camps organized by Lions Clubs International Gandhinagar, Hyderabad and others.

1) Inflammation: Acute inflammation is a defense process whereas chronic inflammation is a disease process. 2) Hyper secretion of mucus: is the result of goblet cell hyperplasia in respiratory mucosa and is a prominent future of inflammation. They go together. Chronic mucus hyper secretion is a potential risk factor for an accelerated loss of lung function. The thick viscous mucus in the lungs will be conducive to pathogens. Currently available medicines and methods are not able to meet the needs of the sufferers. Continued inflammation and mucus hyper secretion may significantly contribute to transformation of normal cells into cancer cells i.e. the scope for series of mutations on Genes may get increased. 3) Bronchospasm: is an additional factor in asthma patients.

Dr. Neeraj Jain is a Top Oncologist in Amritsar, Punjab and one of the leading medical Cancer Doctor in India. The services provided by the doctor are Cancer detection and treatment with Chemotherapy and Radiotherapy, etc. He did MBBS DNB, GMC Amritsar, GNDU ASR, National Board Of Exam, Delhi in 1997. He check two clinics in Amritsar Sri Guru Ram Das Institute of Medical Sciences Amritsar and Dr Ved Gupta Hospital, Mall Road Amritsar

CHEMOTHERAPY AND RADIOTHERAPY